Notably, dysregulation of IRF4 expression and/or activity promotes oncogenesis in several B-cell malignancies, including ABC-DLBCL and Multiple Myeloma (MM)8,18. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.